A nationwide analysis of clinical trial participation for common hepato-pancreato-biliary malignancies demonstrates survival advantages for subsets of trial patients but disparities in and infrequency of enrollment.
暂无分享,去创建一个
K. Chavin | L. Ocuin | D. Bajor | J. Ammori | R. Hoehn | L. Rothermel | J. Hardacre | J. Hue | J. Winter | A. Mohamed | J. Selfridge | Mohamedraed Elshami | M. Elshami